NRG-CC013 - Clinical Trial
Who Can Participate in the Study?
Age Group
Adults
Study Details
Full Title
NRG-CC013: A RANDOMIZED, MASKED, PLACEBO CONTROLLED, PHASE II TRIAL OF CONCURRENT CHEMORADIATION WITH BMX-001 IN PATIENTS WITH HEAD AND NECK SQUAMOUS CELL CARCINOMA RECEIVING CONCURRENT CHEMORADIATION
Principal Investigator
Radiation Oncologist
Protocol Number
IRB:
PRO00117671
NCT:
NCT06532279
Phase
Phase
II
ClinicalTrials.gov
View on ClinicalTrials.gov
Enrollment Status
Open for Enrollment